Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VINILO trial of vinblastine plus nilotinib versus vinblastine alone in recurrent or refractory low-grade glioma
2012-003005-10Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nilotinib and vinblastine in glioma and low-grade glioma (LGG) (2 arms), sponsored by Gustave Roussy. Primary endpoint: Progression-free survival. Started May 2013; status: completed.
02
Drugs
nilotinibvinblastine
03
Conditions
gliomalow-grade glioma (LGG)
Beyond the preview
Go deeper on 2012-003005-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003005-10.